Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03634241 |
Title | Pembrolizumab in Treating Participants With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | M.D. Anderson Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Laura and Isaac Perlmutter Cancer Center at NYU Langone | ACTIVE_NOT_RECRUITING | New York | New York | 10016 | United States | Details |
M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |